Adaptive Biotechnologies (ADPT) Goodwill (2018 - 2026)

Adaptive Biotechnologies has disclosed Goodwill across 9 years of filings, most recently posting $119.0 million for Q2 2026.

• In Q2 2026, Goodwill changed 0.0% year-over-year to $119.0 million; the TTM figure through Jun 2026 stood at $119.0 million (changed 0.0% YoY), while the FY2025 annual figure was $119.0 million, changed 0.0% from the prior year.
• Goodwill came in at $119.0 million for Q2 2026 at Adaptive Biotechnologies, roughly flat from $119.0 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $119.0 million in Q1 2022 to a low of $119.0 million in Q1 2022.
• Average Goodwill over 5 years is $119.0 million, with a median of $119.0 million recorded in 2022.
• The largest YoY upside for Goodwill was 0.0% in 2022 against a maximum downside of 0.0% in 2022.
• Over 5 years, Goodwill stood at $119.0 million in 2022, then changed by 0.0% to $119.0 million in 2023, then changed by 0.0% to $119.0 million in 2024, then changed by 0.0% to $119.0 million in 2025, then changed by 0.0% to $119.0 million in 2026.
• Per Business Quant data, the three most recent Goodwill figures were $119.0 million in Q2 2026, $119.0 million in Q1 2026, and $119.0 million in Q4 2025.